Healthcare provider profile · identity verified

Garron Lamp, MD

Internal Medicine · WOONSOCKET, RI · NPI 1639592462

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	490	89
Eliquis	Apixaban	464	52
Levothyroxine Sodium	Levothyroxine Sodium	459	52
Furosemide	Furosemide	325	56
Pantoprazole Sodium	Pantoprazole Sodium	310	60
Trazodone Hcl	Trazodone Hcl	233	44
Quetiapine Fumarate	Quetiapine Fumarate	224	37
Amlodipine Besylate	Amlodipine Besylate	220	41
Losartan Potassium	Losartan Potassium	204	35
Tamsulosin Hcl	Tamsulosin Hcl	200	39
Metoprolol Tartrate	Metoprolol Tartrate	184	41
Mirtazapine	Mirtazapine	179	42
Jardiance	Empagliflozin	155	20
Potassium Chloride	Potassium Chloride	152	33
Omeprazole	Omeprazole	148	34
Sertraline Hcl	Sertraline Hcl	148	27
Gabapentin	Gabapentin	145	29
Lisinopril	Lisinopril	130	25
Metformin Hcl	Metformin Hcl	130	24
Torsemide	Torsemide	116	21
Citalopram Hbr	Citalopram Hydrobromide	113	16
Montelukast Sodium	Montelukast Sodium	108	17
Duloxetine Hcl	Duloxetine Hcl	99	17
Bumetanide	Bumetanide	95	14
Januvia	Sitagliptin Phosphate	95	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	95	16
Donepezil Hcl	Donepezil Hcl	81	12
Clopidogrel	Clopidogrel Bisulfate	79	22
Fluticasone Propionate	Fluticasone Propionate	79	15
Xarelto	Rivaroxaban	79	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	76	suppressed
Cephalexin	Cephalexin	75	48
Prednisone	Prednisone	74	46
Levetiracetam	Levetiracetam	69	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	68	23
Carvedilol	Carvedilol	66	15
Hydralazine Hcl	Hydralazine Hcl	66	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	64	44
Divalproex Sodium	Divalproex Sodium	64	suppressed
Metoprolol Succinate	Metoprolol Succinate	64	23
Finasteride	Finasteride	63	12
Allopurinol	Allopurinol	61	14
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	61	12
Famotidine	Famotidine	61	13
Spironolactone	Spironolactone	61	12
Baclofen	Baclofen	60	suppressed
Warfarin Sodium	Warfarin Sodium	60	suppressed
Aripiprazole	Aripiprazole	58	suppressed
Atenolol	Atenolol	58	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	12
Symbicort	Budesonide/Formoterol Fumarate	51	suppressed
Budesonide	Budesonide	50	suppressed
Ertapenem	Ertapenem Sodium	50	19
Lactulose	Lactulose	50	suppressed
Simvastatin	Simvastatin	50	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	46	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	31
Metoclopramide Hcl	Metoclopramide Hcl	43	suppressed
Albuterol Sulfate	Albuterol Sulfate	41	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	17
Lantus	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Olanzapine	Olanzapine	40	suppressed
Risperidone	Risperidone	39	suppressed
Lovastatin	Lovastatin	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	36	suppressed
Ursodiol	Ursodiol	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Hydrocortisone	Hydrocortisone	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	16
Clozapine	Clozapine	32	suppressed
Levofloxacin	Levofloxacin	32	26
Rasagiline Mesylate	Rasagiline Mesylate	32	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	31	31
Memantine Hcl	Memantine Hcl	31	suppressed
Latanoprost	Latanoprost	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	14
Lamotrigine	Lamotrigine	27	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	16
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Glipizide	Glipizide	23	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Lubiprostone	Lubiprostone	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Tacrolimus	Tacrolimus	21	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Lidocaine Hcl	Lidocaine Hcl	20	14
Lidocaine Hcl	Lidocaine Hcl/Pf	20	11
Oseltamivir Phosphate	Oseltamivir Phosphate	20	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Azithromycin	Azithromycin	19	15
Nystatin	Nystatin	19	suppressed
Ondansetron Odt	Ondansetron	19	12
Pentasa	Mesalamine	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Ceftriaxone	Ceftriaxone Sodium	18	12
Klor-Con 10	Potassium Chloride	18	suppressed
Lithium Carbonate	Lithium Carbonate	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Propylthiouracil	Propylthiouracil	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Ssd	Silver Sulfadiazine	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	12
Fluticasone Propionate Hfa	Fluticasone Propionate	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Linezolid	Linezolid	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Colchicine	Colchicine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sodium Chloride	Sodium Chloride 0.45 %	14	11
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Topiramate	Topiramate	13	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Etodolac	Etodolac	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Perphenazine	Perphenazine	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error